Lin YW - Search Results

1

Induction of Rad51 protein levels by p38 MAPK decreases cytotoxicity and mutagenicity in benzo[a]pyrene-exposed human lung cancer cells.

Chuang SM, Wang LH, Hong JH, Lin YW. Chuang SM, et al. Among authors: lin yw. Toxicol Appl Pharmacol. 2008 Aug 1;230(3):290-7. doi: 10.1016/j.taap.2008.03.001. Epub 2008 Mar 12. Toxicol Appl Pharmacol. 2008. PMID: 18430445

2

Persistent activation of ERK1/2 by lead acetate increases nucleotide excision repair synthesis and confers anti-cytotoxicity and anti-mutagenicity.

Lin YW, Chuang SM, Yang JL. Lin YW, et al. Carcinogenesis. 2003 Jan;24(1):53-61. doi: 10.1093/carcin/24.1.53. Carcinogenesis. 2003. PMID: 12538349

3

ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway.

Lin YW, Chuang SM, Yang JL. Lin YW, et al. J Biol Chem. 2003 Jun 13;278(24):21534-41. doi: 10.1074/jbc.M301854200. Epub 2003 Apr 3. J Biol Chem. 2003. PMID: 12676937 Free article.

4

The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer.

Ko JC, Hong JH, Wang LH, Lin YW. Ko JC, et al. Among authors: lin yw. Exp Cell Res. 2008 May 1;314(8):1881-91. doi: 10.1016/j.yexcr.2008.02.013. Epub 2008 Mar 4. Exp Cell Res. 2008. PMID: 18377894

5

Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells.

Ko JC, Ciou SC, Cheng CM, Wang LH, Hong JH, Jheng MY, Ling ST, Lin YW. Ko JC, et al. Among authors: lin yw. Carcinogenesis. 2008 Jul;29(7):1448-58. doi: 10.1093/carcin/bgn130. Epub 2008 Jun 9. Carcinogenesis. 2008. PMID: 18544565

6

Activation of protein kinase Calpha signaling prevents cytotoxicity and mutagenicity following lead acetate in CL3 human lung cancer cells.

Wang CY, Lin YW, Yang JL. Wang CY, et al. Among authors: lin yw. Toxicology. 2008 Aug 19;250(1):55-61. doi: 10.1016/j.tox.2008.06.001. Epub 2008 Jun 11. Toxicology. 2008. PMID: 18590793

7

Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells.

Ko JC, Hong JH, Wang LH, Cheng CM, Ciou SC, Lin ST, Jheng MY, Lin YW. Ko JC, et al. Among authors: lin st, lin yw. Mol Cancer Ther. 2008 Nov;7(11):3632-41. doi: 10.1158/1535-7163.MCT-08-0578. Mol Cancer Ther. 2008. PMID: 19001445

8

The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells.

Ko JC, Wang LH, Jhan JY, Ciou SC, Hong JH, Lin ST, Lin YW. Ko JC, et al. Among authors: lin st, lin yw. Lung Cancer. 2009 Sep;65(3):290-8. doi: 10.1016/j.lungcan.2008.12.008. Epub 2009 Jan 20. Lung Cancer. 2009. PMID: 19157634

9

Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation.

Chen RS, Jhan JY, Su YJ, Lee WT, Cheng CM, Ciou SC, Lin ST, Chuang SM, Ko JC, Lin YW. Chen RS, et al. Among authors: lin st, lin yw. Exp Cell Res. 2009 Sep 10;315(15):2658-72. doi: 10.1016/j.yexcr.2009.06.002. Epub 2009 Jun 6. Exp Cell Res. 2009. PMID: 19505457

10

Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells.

Ko JC, Ciou SC, Jhan JY, Cheng CM, Su YJ, Chuang SM, Lin ST, Chang CC, Lin YW. Ko JC, et al. Among authors: lin st, lin yw. Mol Cancer Res. 2009 Aug;7(8):1378-89. doi: 10.1158/1541-7786.MCR-09-0051. Epub 2009 Aug 11. Mol Cancer Res. 2009. PMID: 19671683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,126 results

Search Page

Filters